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ABSTRACT
The present study was carried out to evaluate the effect of piperine pre-conditioning on the pharmacokinetics 
of marbofloxacin in Wistar rats. Marbofloxacin was administrated at a dose rate of 5 mg/kg body weight alone, and 
along with piperine pre-conditioning at a dose of 10 mg/kg of body weight, orally for 5 days in Wistar rats. The mean 
values of the half-life (t½β), maximum drug concentration (Cmax) and area under the curve (AUC) were 1.19 ± 0.17 h, 
2.71 ± 0.09 μg/mL and 12.25 ± 0.77 μg.h/mL, respectively, in piperine pretreated rats. The values were significantly 
higher than the values observed in rats administered with marbofloxacin alone (1.12 ± 0.31 h, 2.28 ± 0.20 μg/mL 
and 9.24 ± 0.59 μg.h/mL, respectively). The drug clearance (ClB) in piperine pretreated rats was 0.04 ± 0.02 L/h/kg, 
which was significantly lower than the clearance rate of the drug (0.53 ± 0.03 L/h/kg) in the animals administered with 
marbofloxacin alone. The study reveals that piperine has a significant effect on the pharmacokinetics of marbofloxacin, 
which may be due to an increase in the drug absorption and inhibition of elimination of the drug in rats. 
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along with antibacterial drugs (HIWALE et al., 
2002). Pretreatment with piperine has been shown 
to increase the rate and extent of absorption of some 
of drugs widely used in human medicine, which are 
moderately absorbed on their own by enhancement 
of the blood supply through vasodilatation, 
inhibition of their metabolism, or inhibition of renal 
clearance (ATAL, 1979). An important role played 
by piperine in metabolism is the inhibition of hepatic 
monooxygenase and UDP-glucouronyltransferase, 
intestinal glucouronidation, and inhibition of 
CYP3A4 and p-glycoprotein (BHARDWAJ et al., 
2002). 
Introduction
Antibacterial agents are important drugs as 
they are frequently used to treat various infectious 
diseases. Increasing bacterial resistance is due to 
lower absorption of drugs and the failure to achieve 
the therapeutic drug concentration. To solve 
this problem, the dose rate of the antimicrobial 
agent has to be increased, which may lead to an 
increase in adverse effects. A bio-enhancer with 
antimicrobial agents may be useful to increase 
the bioavailability of drugs. Piperine is an active 
component of Piper longum L. and Piper nigrum 
L. which has bio-enhancing property when given 
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Marbofloxacin is a bactericidal agent with broad 
spectrum of activity against Gram-negative, some 
Gram-positive bacteria and Mycoplasma spp. The 
in vivo and in vitro efficacy of the drug against 
Staphylococcus intermedius, Escherichia coli, 
Proteus mirabilis, Pseudomonas spp., Pasteurella 
multocida, and Mannheima haemolytica have been 
reported (SHOJAEE and LEES, 1997; SPRENG 
et al., 1995). Evaluation of the pharmacokinetics 
of marbofloxacin in various animal species has 
revealed that the drug is poorly absorbed in animals 
following oral administration. Notwithstanding 
its broad spectrum of activity, its therapeutic 
effectiveness is altered by its poor bioavailability 
through the oral route. One practical approach 
to enhance its bioavailability is using herbal 
bio-enhancers with the antibacterial agents. It 
would be rational and judicious to study the 
pharmacokinetics of newer antimicrobial drugs 
with bio-enhancers such as piperine. The continued 
interest in marbofloxacin has led to several recent 
investigations describing its pharmacokinetics 
in various species of domestic animals, such as 
cattle (BELEW et al., 2015), goats (SIDHU et al., 
2010), horses (BOUSQUET-MELOU et al., 2002), 
poultry (DE LUCAS et al., 2005), dog (HEINEN, 
2002) camels (LACHGUER et al., 2013) and 
rabbits (CARPENTER et al., 2006). The effect of 
piperine on the pharmacokinetics of ciprofloxacin 
and norfloxacin was studied by BHISE and PORE 
(2002) and JANAKIRAMAN MANAVALAN 
(2008). However, data are not available in relation 
to the effect of piperine pre-conditioning for five 
days on the pharmacokinetics of marbofloxacin in 
rats. 
Materials and methods
Experimental animals. In this study, twelve male 
albino Wistar rats (Rattus norvegicus) of 10-12 
weeks of age and 250 ± 10 g in weight were obtained 
from Cadila Pharmaceutical Pvt. Ltd., Dholka, 
Ahmedabad, Gujarat. They were maintained as per 
the guidelines of the Committee for the Purpose 
of Control and Supervision of Experiments on 
Animals. The experimental protocol, including the 
number of rats and the various procedures involved, 
was approved by the Institutional Animal Ethics 
Committee (No. JAU/JVC/IAEC/SA/08/16). 
Animal husbandry. The rats were housed in 
standard polypropylene cages at room temperature 
between 23 to 26 °C, and relative humidity ranging 
from 40 to 55%. A twelve hour light-dark cycle 
was maintained in the animal room. Rat pelleted 
feed (VRK biological system, Vadodara, Gujarat, 
India) containing 18% protein was provided for the 
animals. 
Drug and chemicals. Marbofloxacin technical 
grade powder was obtained from Sigma Aldrich, 
USA. Marbofloxacin tablets (50 mg) and 
marbofloxacin injections (100 mg/mL, 30 mL multi 
dose vials) were used in the study. Piperine was 
procured from Sigma Aldrich, Bangalore, India. 
Water, acetonitrile and formic acid of HPLC grade 
were purchased from S. D. Fine Chem. Ltd., and 
Merck India Ltd., Mumbai.
Experimental design. Twelve albino rats were 
equally divided through randomization with 
minimum variations in body weight ( ± 10%) into 
two groups of 6 animals each. Rats in group I were 
treated with a single oral dose of marbofloxacin (5 
mg/kg) and in group II with piperine (10 mg/kg, 
PO for 5 days), followed by single oral dose of 
marbofloxacin (5 mg/kg, PO).
Drug administration and collection of samples. 
Marbofloxacin and piperine were administered 
by oral route using a graduated syringe with an 
intubation cannula at the dose of 5 and 10 mg/
kg body weight, respectively. Blood samples 
(approximately 0.250 mL) were collected from 
the retro orbital plexus under light anesthesia. 
Following oral administration of marbofloxacin, 
blood samples were collected at 0 minute (before 
drug administration), 5 (0.083 h), 15 (0.25 h) and 30 
(0.5 h) minutes and at 1, 2, 4, 8, 12 and 24 h. Plasma 
was separated after centrifugation (Eppendorf 5430 
R, Germany) of blood samples at 14000 revolutions 
per minute (rpm) for 10 minutes at 4 °C. The 
plasma samples were transferred to cryo-vials (2 
mL capacity) and then stored at -20 °C until being 
assayed for marbofloxacin concentration using 
HPLC.
Marbofloxacin assay. Plasma concentrations 
of marbofloxacin were determined by High 
Performance Liquid Chromatography (HPLC), with 
a slight modification of the flow rate of the mobile 
phase described by CARPENTER et al. (2006).
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High performance liquid chromatography 
apparatus by Schimadzu (Japan)-LC-2010 CHT, 
comprising a quaternary gradient delivery pump 
(LC-2010) and a UV detector was used for assay. 
Chromatographic separation was performed using a 
reverse phase C18 column (Thermo, ODS; 250 × 4 
mm ID, 5 micron) at 30 °C. HPLC data integration 
was performed using LC solution software 
(Shimadzu).
The mobile phase was a mixture of 10 mM 
formic acid (80%) and acetronirile (20%), and the 
pH of 5.1 was adjusted with ortho-phosphoric acid. 
The mobile phase was filtered through 0.45 µ size 
filter paper (Millipore India Pvt., Ltd., Bangalore) 
and degassed by ultra-sonication. The mobile phase 
was pumped into the column at a flow rate of 0.75 
mL/minute. The effluent was monitored at 295 nm 
wavelength.
The plasma samples were deproteinized using 
perchloric acid. Briefly, 100 µL of 0.8 M perchloric 
acid was added to 100 µL of each plasma sample. 
After mixing for 2-3 minutes, the samples were 
centrifuged at 12000 rpm for 10 minutes. The clean 
supernatant was collected in an HPLC vial with 
insert. Twenty microliters of the supernatant was 
injected intothe HPLC system for analysis through 
an auto sampler.
For standardization, a stock solution of 
marbofloxacin was prepared initially by adding 
1 mg pure marbofloxacin powder to 1 mL 
HPLC water. The known standard solutions of 
marbofloxacin for constructing the calibration 
graph were prepared by serial dilution of a stock 
standard solution in HPLC water and the drug free 
plasma of the rats. The stock solution was used to 
prepare standard marbofloxacin concentrations of 
0.039, 0.078, 0.156, 0.312, 0.625, 1.25, 2.5, 5, 10, 
and 20 μg/mL. Each standard prepared in plasma 
was then treated by the steps described earlier for 
extraction of marbofloxacin. Twenty microliters of 
supernatant was injected through the auto sampler 
into the HPLC. 
Pharmacokinetic analysis and statistical 
analysis. The pharmacokinetic parameters were 
calculated on the basis of the plasma concentration 
of marbofloxacin after its single dose oral 
administration at 5 mg/kg of body weight in the 
piperine pretreated rats and alone, according to 
the formulas described by BAGGOT (1977) and 
GIBALDI and PERRIER (1982). All data obtained 
are presented as mean ± standard error (SE). Data 
were analyzed statistically by student’s t-test (using 
Microsoft Office Excel® software) to observe 
differences between the treatment groups.
Results
The mean plasma drug concentrations at 
different time points, following a single oral dose 
administration of the marbofloxacin alone (5 mg/
kg) and along with piperine pre-conditioning (10 
mg/kg, PO for 5 day) in rats, are depicted in Fig. 1. 
Fig. 1. Semi-logarithmic plot of concentrations of marbofloxacin in plasma versus time after oral administration  
(5 mg/kg) alone and along with piperine pre-conditioning (10 mg/kg oral for 5 days) in rats.*Significant at P<0.05
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The pharmacokinetic parameters of marbofloxacin, 
following single oral dose administration of the 
marbofloxacin alone and along with piperine pre-
conditioning (10 mg/kg, PO for 5 day) in rats, are 
presented in Table 1. 
Table 1. Comparison of the pharmacokinetic parameters (Mean ± SE) of marbofloxacin after oral administration (5 
mg/kg) alone and along with piperine pre-conditioning (10 mg/kg oral for 5 days) in rats (Mean ± SE, n = 6)
Pharmacokinetic 
parametera Unit
(Group I)  
Marbofloxacin alone
(Group II) 
Piperine pre-treatment + Marbofloxacin
Β h-1 0.13 ± 0.01 0.12 ± 0.01
t½β h 5.54 ± 0.40 5.94 ± 0.41
Α' h-1 0.86 ± 0.22 0.65 ± 0.10
t½α h 1.12 ± 0.31 1.19 ± 0.17
Ka h-1 3.03 ± 0.58 3.59 ± 0.41
t½Ka h 0.26 ± 0.04 0.20 ± 0.02
Cmax µg/mL 2.28 ± 0.20 2.71 ± 0.09*
Tmax h 0.92 ± 0.08 1.00 ± 0.00
AUC(0-t) µg.h/mL 9.24 ± 0.59 12.25 ± 0.77**
AUC(0- ∞) µg.h/mL 9.58 ± 0.56 12.74 ± 0.73**
AUMC µg.h2/mL 54.98 ± 0.39 73.95 ± 2.90**
MRT h 5.83 ± 0.50 5.85 ± 0.22
Vd(area) L/kg 4.29 ± 0.50 3.46 ± 0.36
Vd(ss) L/kg 3.14 ± 0.42 2.34 ± 0.08
Cl(B) L/h/kg 0.53 ± 0.03 0.40 ± 0.02**
*Significant at P<0.05, **Highly significant at P<0.01, a - β, elimination rate constant; α - distribution rate constant; A’ - intercept 
of absorption phase; Ka - absorption rate constant; t1/2ka - absorption half-life; t½α - distribution half-life; t½β - elimination half-life; 
Cmax - the peak or maximum plasma concentrations; Tmax - the time to reach peak or maximum plasma concentration; AUC - area 
under the plasma concentration - time curve; AUMC - area under the moment curve; MRT - mean resident time; Vd(area) - volume 
of distribution; Vd(ss) - volume of distribution of drug at steady-state; Cl(B) - total body clearance of drug
Discussion 
In the present study, the maximum marbofloxacin 
concentration (Cmax) observed in the piperine 
pretreated group was significantly (P<0.05) higher 
than that observed in animals treated with the 
drug alone. Similarly, a higher plasma drug level 
(Cmax) of 8.0 ± 0.34 µg/mL at 1.0 ± 0.22 h after oral 
administration of ampicillin along with piperine 
(10 mg/kg) in rats was reported by HIWALE et 
al. (2002). The findings of the present study are 
in agreement with report by PATEL et al. (2011), 
who observed higher concentrations (Cmax) of 
gatifloxacin when it was administered with piperine. 
Following oral administration of marbofloxacin 
in piperine pre-treated rats, the plasma levels of the 
drug were significantly higher at 0.08333, 0.25, 0.5 
and 4 h (P<0.05) than those values obtained after 
single oral administration of marbofloxacin alone. 
The present finding was similar to an earlier report 
that mentioned higher plasma concentrations of 
marbofloxacin in piperine pretreated rats throughout 
its entire absorption phase, which might be due to 
increased permeability into the gastro intestinal 
tract epithelium cell membrane (ANNAMALAI 
and MANAVALAN, 1989). However, the minimal 
detectable level of drug (0.04 ± 0.005 µg/mL) in 
the group administered with marbofloxacin alone 
did not differ significantly (P>0.05) from the level 
(0.06 ± 0.00 µg/mL) observed in the piperine pre-
treated group. 
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A non-significantly lower value of the apparent 
volume of distribution (Vdarea) was observed in the 
piperine pretreated group as compared to the only 
marbofloxacin group. The finding is supported 
by the finding of a similar volume of distribution 
in layer birds (3.33 ± 0.083 L/kg) following the 
oral administration of gatifloxacin along with 
piperine co-administration (PATEL et al., 2011). 
A non-significant difference was observed in the 
elimination half-life and mean residence time 
(MRT) in the piperine pretreated group as compared 
to those of the only marbofloxacin group. 
The higher values of AUC and AUMC in 
piperine treated rats were indicative of the 
enhanced systemic availability of marbofloxacin, 
which might be due to suppression of the drug’s 
metabolizing activities. Piperine, the active 
principle of P. longum, has been shown to inhibit 
drug metabolizing activities (REEN et al., 1997). 
Piperine has shown a bio-enhancing effect on 
the absorption of co-administered drugs such as 
sulphadiazine, pyrazinamide, rifampin, isoniazid 
in human volunteers (ZUTSHI, 1985). The present 
findings are supported by previous reports by 
HIWALE et al., (2002) and PATEL et al., (2011) 
who observed higher values of AUC in rats (17.80 
± 0.41 µg.h/mL) and layer birds (17.54 ± 0.20 µg.h/
mL), following oral administration of amoxicillin 
and gatifloxacin with piperine, respectively. 
A significantly lower value of total body 
clearance in piperine pretreated rats was 
observed as compared to rats administered with 
marbofloxacin alone. This finding is in agreement 
with the clearance of gatifloxacin (0.57 ± 0.00 
L/h/kg) reported, following its oral administration 
along with piperine co-administration, in layer 
birds (PATEL et al., 2011). This result indicates the 
comparatively slower clearance of marbofloxacin 
following oral administration in piperine pre-treated 
rats, and suggests the higher tubular reabsorption 
of the drug and excretion of the drug through 
glomerular filtration. 
In the present study, the observations related to 
the longer elimination half-life of the marbofloxacin 
in piperine pre-treated rats are similar to those 
reported by SINGH et al. (2005), who documented 
the longer elimination half-life of oxytetracycline 
(6.37 ± 0.44 h) in hens after its administration 
along with piperine. The elimination half-life of 
marbofloxacin following single oral administration 
in the piperine pre-treated rats is similar to the value 
of the elimination half-life (t½β) of gatifloxacin (4.03 
± 0.09 h) after oral administration in layer birds 
(PATEL et al., 2011). This increase in the elimination 
half-life of marbofloxacin indicates the inhibitory 
effect of piperine on the elimination phase due to 
a decrease in renal clearance (SRINIVAS et al., 
2008). Alterations in the pharmacokinetic profile of 
marbofloxacin by piperine pre-conditioning might 
be due to the increased permeability of the gastro 
intestinal tract epithelial cell membrane, inhibition 
of drug metabolizing enzymes and suppression of 
the first pass metabolism of the marbofloxacin by 
piperine. 
Conclusion
Piperine pre-conditioning altered the maximum 
drug concentration, the area under the curve, the area 
under the moment curve and total body clearance of 
marbofloxacin after oral administration in rats. 
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SAžETAK
U ovom je radu istražen učinak pretkondicioniranja piperinom na farmakokinetiku marbofloksacina Wistar štakora. 
Marbofloksacin je apliciran u dozi od 5 mg/kg tjelesne mase peroralno, samostalno i nakon pretkondicioniranja 
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piperinom u dozi od 10 mg/kg tjelesne mase peroralno tijekom 5 dana. U štakora tretiranih piperinom prosječne 
vrijednosti poluživota (t½β) bile su 1,19 ± 0,17 h, maksimalna koncentracija lijeka (Cmax) 2,71 ± 0,09 μg/mL, a površina 
ispod krivulje (AUC) 12,25 ± 0,77 μg.h/mL. Navedene vrijednosti bile su znakovito više od onih utvrđenih u štakora 
tretiranih samo marbofloksacin (1,12 ± 0,31 h, 2,28 ± 0,20 μg/mL i 9,24 ± 0,59 μg.h/mL). Klirens lijeka (ClB) u 
štakora tretiranih piperinom bio je 0,04 ± 0,02 L/h/kg što je bilo znakovito niže od klirensa lijeka (0,53 ± 0,03 L/h/
kg) u životinja koje su dobivale samo marbofloksacin. Ovo istraživanje pokazuje da piperin znakovito utječe na 
farmakokinetiku marbofloksacina, što može biti posljedica povećane apsorpcije lijeka i inhibicije uklanjanja lijeka u 
štakora. 
Ključne riječi: pretkondicioniranje piperinom; farmakokinetika; marbofloksacin; Wistar štakori_____________________________________________________________________________________________

